IHC News and Research

RSS
Researchers uncover distinct cell vulnerabilities in Alzheimer’s progression with novel multiomics approach

Researchers uncover distinct cell vulnerabilities in Alzheimer’s progression with novel multiomics approach

Dietary antigens reduce small intestine cancer by boosting immune T-cells

Dietary antigens reduce small intestine cancer by boosting immune T-cells

AI tool enhances cancer diagnosis by transforming standard tissue images

AI tool enhances cancer diagnosis by transforming standard tissue images

A novel therapeutic option for HER2-positive extramammary Paget disease

A novel therapeutic option for HER2-positive extramammary Paget disease

UCLA team develops automated HER2 scoring system with deep learning and pyramid sampling

UCLA team develops automated HER2 scoring system with deep learning and pyramid sampling

New AI test may help bowel cancer patients avoid unnecessary chemotherapy

New AI test may help bowel cancer patients avoid unnecessary chemotherapy

Deciphering the role of RET in cancer and breakthroughs in targeted treatments

Deciphering the role of RET in cancer and breakthroughs in targeted treatments

Study identifies RFC4 as key player in nasopharyngeal carcinoma

Study identifies RFC4 as key player in nasopharyngeal carcinoma

Researchers identify shared molecular mechanism in cancer and pregnancy that suppresses immune system

Researchers identify shared molecular mechanism in cancer and pregnancy that suppresses immune system

New WHO classification of kidney tumors integrates molecular diagnostics

New WHO classification of kidney tumors integrates molecular diagnostics

Microplastics: Invisible to the eye but severely harmful to pregnancy and metabolic outcomes

Microplastics: Invisible to the eye but severely harmful to pregnancy and metabolic outcomes

Study finds human body lice can transmit plague bacteria

Study finds human body lice can transmit plague bacteria

Phase 1 trial for EBC-129 progresses into dose expansion

Phase 1 trial for EBC-129 progresses into dose expansion

Non-viral gene therapy offers hope for chronic low back pain sufferers

Non-viral gene therapy offers hope for chronic low back pain sufferers

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

How immune cells shape our earliest breaths

How immune cells shape our earliest breaths

New study expands immunotherapy eligibility for colorectal and endometrial cancer patients

New study expands immunotherapy eligibility for colorectal and endometrial cancer patients

Study unlocks protein clues to aggressive lymphoma transformation

Study unlocks protein clues to aggressive lymphoma transformation

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.